Time since stopping smoking and the risk of oral and pharyngeal cancers by C.V.B. LA VECCHIA et al.
-Time Since Stopping Smoking
and the Risk of Oral and
Pharyngeal Cancers
In the largest study to date of oral and
pharyngeal cancers that contained 1114
case subjects and 1268 control subjects
from four areas of the United States,
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cessation of smoking was associated
with a sharply and markedly reduced
risk (1). The odds ratio (OR) for all cur-
rent smokers combined was 3.4 for
males and 4.7 for females. For ex-
smokers (i.e., subjects who had not
smoked for at least 1 year), the OR was
1.1 for males and 1.8 for females 1–9
years after smoking cessation, 1.1 for
males and 0.8 for females 10–19 years
after cessation, and 0.7 for males and 0.4
for females 20 years or longer after ces-
sation.
Such a drop in risk in a relatively
short time suggested that smoking
mainly affects the later stages of oral
and pharyngeal carcinogenesis (1) and,
if confirmed, would have relevant public
health implications. However, the U.S.
veterans cohort study (2) showed el-
evated risks of oral (relative risk 4 1.5)
and pharyngeal (relative risk 4 2.6)
cancers in all former smokers combined.
To clarify the issue, we decided to
assess the pattern of risk of oral and pha-
ryngeal cancers after a person stops
smoking by analyzing the combined re-
sults of two case–control studies, the
first conducted in Italy (3) and the sec-
ond conducted in Italy and Switzerland
(4). Briefly, from 1984 through 1997,
data were collected by trained inter-
viewers on 1280 case subjects, younger
than 75 years old, who had incident, his-
tologically confirmed oral and pharyn-
geal cancers (638 patients with oral can-
cer and 642 patients with pharyngeal
cancer, 1085 males and 195 females)
and who were admitted to a network of
hospitals in the greater Milan area and
Pordenone (northern Italy), Rome and
Latina (central Italy), and the Swiss
Canton of Vaud. Control subjects were
4179 patients (3068 males and 1111 fe-
males) admitted to the same network of
hospitals for acute, nonneoplastic condi-
tions that were unrelated to alcohol or
tobacco consumption.
Table 1 gives the distribution for the
groups of patients with oral and pharyn-
geal cancers and the comparison group,
according to smoking status and time
since cessation. The overall multivariate
OR, after allowance for study center,
age, sex, education, and alcohol drink-
ing, was 8.4 for current smokers.
Among ex-smokers, the ORs were 6.2
for those who had stopped smoking for
less than 2 years, 4.5 for those who had
stopped for 3–5 years, 3.5 for those who
had stopped for 6–9 years, 1.6 for those
who had stopped for 10–14 years, and
1.4 for those who had stopped for 15 or
more years. For oral cancer, the OR was
2.9 for those who had stopped smoking
for 6–9 years, but was no longer above
unity after 10 or more years. For pha-
ryngeal cancer, which in Italy and Swit-
zerland represents a higher proportion of
cases than in North America (1,2), the
OR was 3.2 for those who had stopped
smoking for 10–14 years and 2.9 for
those who had stopped for 15 years or
longer.
For ex-smokers, the relative risk of
lung cancer declines with time since
stopping smoking, to reach asymptoti-
cally the relative risk of never smokers,
but is still above that of never smokers
(i.e., subjects who had never smoked at
least one cigarette per day for at least 1
year) 10 or more years after stopping
(5–7). The pattern of risk for oral and
pharyngeal cancers observed in this
study suggests the existence of similari-
ties in the process of carcinogenesis for
these major tobacco-related neoplasms.
The decrease in risk, however, may be
steeper for oral cancer.
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Table 1. Distribution of data from 638 oral cancer case subjects, 642 pharyngeal cancer case subjects, and 4179 control subjects,
according to smoking status* and time since smoking cessation, and corresponding odds ratios (ORs)† and 95% confidence intervals (CIs)
for data from Italy and Switzerland (1984 through 1997)
Oral Pharyngeal Control subjects OR (95% CI)
No. (%) No. (%) No. (%) Oral Pharyngeal Total
Never smokers 70 (11.0) 32 (5.0) 1556 (37.2) 1‡ 1‡ 1‡
Current smokers 441 (69.1) 459 (71.5) 1456 (34.8) 6.18 (4.62–8.26) 13.45 (9.13–19.81) 8.36 (6.57–10.64)
Ex-smokers, time since smoking cessation, y
1–2 28 (4.4) 31 (4.8) 127 (3.0) 4.64 (2.77–7.76) 9.88 (5.59–17.47) 6.22 (4.14–9.34)
3–5 38 (6.0) 28 (4.4) 195 (4.7) 3.93 (2.49–6.21) 6.27 (3.58–10.98) 4.53 (3.11–6.59)
6–9 31 (4.8) 27 (4.2) 183 (4.5) 2.89 (1.78–4.67) 4.78 (2.72–8.40) 3.45 (2.34–5.08)
10–14 12 (1.9) 26 (4.0) 238 (5.7) 0.82 (0.42–1.60) 3.23 (1.83–5.71) 1.62 (1.05–2.50)
ø15 18 (2.8) 39 (6.1) 424 (10.1) 0.71 (0.41–1.24) 2.87 (1.73–4.75) 1.42 (0.98–2.05)
*Smoking status: never smoker 4 subject who had never smoked at least one cigarette per day for at least 1 year; current smoker 4 smoker of greater than
or equal to 1 cigarette per day; and ex-smoker 4 subject who had not smoked for more than 1 year.
†Derived from unconditional multiple logistic regression models, including terms for age, sex, study center, education, and alcohol drinking.
‡Reference category.
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in former smokers. J Natl Cancer Inst 1993;
85:457–64.
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